Mark Santillo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Cross Sectional

Klebsiella Pneumoniae

Mesenchymal Stem Cells

Top Venues

JAC-antimicrobial resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)